AbbVie (ABBV) EV to EBIT (2012 - 2026)
AbbVie's (ABBV) quarterly EV to EBIT came in at 68.12 in Q2 2026, up 3.7% year-over-year from 65.69 in Q2 2025, and down 27.5% quarter-over-quarter from 93.96 in Q1 2026.
Powered by 
Analysis
AbbVie (ABBV) EV to EBIT (2012 - 2026) Analysis & Trends
AbbVie (ABBV) has reported EV to EBIT for 15 consecutive years, with 68.12 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to EBIT rose 3.7% year-over-year to 68.12 in Q2 2026; TTM through Jun 2026 was 25.97, a 11.39% decrease from a year earlier, with the FY2025 full-year figure at 26.45, down 21.57% from the prior year.
- EV to EBIT was 68.12 for Q2 2026 at AbbVie, down from 93.96 in the prior quarter.
- Over five years, EV to EBIT peaked at 211.97 in Q3 2025 and troughed at 206.84 in Q4 2024.
- A 5-year average of 70.41 and a median of 80.43 in 2022 frame the typical range for EV to EBIT.
- Across the five-year window, EV to EBIT slumped 353.23% in 2024 and soared 142.43% in 2025, its largest moves.
- Over 5 years, EV to EBIT stood at 50.3 in 2022, then jumped by 62.38% to 81.68 in 2023, then plunged by 353.23% to 206.84 in 2024, then soared by 142.43% to 87.76 in 2025, then slipped by 22.38% to 68.12 in 2026.
- The last three EV to EBIT figures came in at 68.12 (Q2 2026), 93.96 (Q1 2026), and 87.76 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 68.12 |
| Mar 31, 2026 | 93.96 |
| Dec 31, 2025 | 87.76 |
| Sep 30, 2025 | 211.97 |
| Jun 30, 2025 | 65.69 |
| Mar 31, 2025 | 97.77 |
| Dec 31, 2024 | -206.84 |
| Sep 30, 2024 | 89.20 |
| Jun 30, 2024 | 72.50 |
| Mar 31, 2024 | 108.48 |
| Dec 31, 2023 | 81.68 |
| Sep 30, 2023 | 109.56 |
| Jun 30, 2023 | 50.76 |
| Mar 31, 2023 | 99.16 |
| Dec 31, 2022 | 50.30 |
| Sep 30, 2022 | 48.99 |
| Jun 30, 2022 | 79.17 |
| Mar 31, 2022 | 59.13 |
| Dec 31, 2021 | 45.27 |
| Sep 30, 2021 | 41.45 |